White Papers
-
Achieving Statistical Significance With Limited Patient Populations
3/15/2024
Explore highlights from a timely panel debate on emerging approaches to clinical research and data collection for advanced, novel and personalized therapies, especially linked to rare diseases.
-
Digital Endpoint Resource Guide: Neuromuscular Disorders
3/15/2024
Find out how sensor-based digital health technologies (DHTs) offer direct, objective daily life assessments, accelerating NMD drug development.
-
Bringing In Vitro Diagnostics To Market With Real-World Evidence
3/14/2024
Explore the potential of real-world evidence in enhancing the regulatory decision-making process to facilitate the market entry of IVDs.
-
Study Start-Up Challenges: Hard Realities, Effective Strategies
3/13/2024
Launching a study is complex, and the time between protocol approval and the first patient visit has increased dramatically. How can companies reverse this trend and accelerate study start-ups?
-
eConsent Readiness In 24 Countries
3/12/2024
Discover how regulatory bodies worldwide, including the U.S. Food and Drug Administration and the European Medicines Agency, are now championing the shift towards eConsent adoption.
-
Precision Oncology Clinical Trials And Statistics 2024
3/12/2024
Delve into the latest advancements in clinical trials, targeted therapies, and the promising horizon of cancer care.
-
Quality By Design: Better Data Using Participant Insights
3/12/2024
While clinical trials will always encounter challenges in driving quality experiences and data, there exists one approach that’s backed by regulatory agencies and proven to lead to better outcomes.
-
eCOA Licensing Guide
3/7/2024
In this comprehensive guide, IQVIA's eCOA library and licensing specialists, Kayla Doyle and Piero Bindi, explore five essential steps for obtaining licenses for the assessments required in your clinical trial.
-
The Importance Of An Implementation Lead Within FSP Models
3/7/2024
Uncover how the role of the Implementation Lead from PPD™ FSP ensures streamlined and expertly managed onboarding and resource allocation for FSP clinical research projects.
-
PV Solutions Optimizing End-To-End Safety In Clinical Development
3/6/2024
Explore what the future of PV services and technology in the life sciences industry could look like if innovation, regulatory vigilance, and collaboration with regulatory bodies were prioritized.